Clinical Trials Browser

Phase 1 × Leukemia, Plasma Cell × Bendamustine Hydrochloride × Clear all

NCT02315157 2025-10-15

Bendamustine Hydrochloride in Treating Patients With Previously Treated Multiple Myeloma

Phase 1 Withdrawn

Other hematologic neoplasmPlasma cell

Leukemia, Plasma Cell, Multiple Myeloma